Related Experiment Videos
[Transfer of delayed type hypersensitivity in guinea pigs].
1Instytut Matki i Dziecka.
Problemy Medycyny Wieku Rozwojowego
|January 1, 1990
Summary
Transfer factor, a leukocyte-derived molecule, facilitates the transfer of delayed-type hypersensitivity (DTH). Research explores its potential therapeutic applications and in vitro assays for activity, despite undefined chemical structure.
Area of Science:
- Immunology
- Cellular Biology
Context:
- Transfer factor (TF) is a leukocyte-derived substance known to transfer delayed-type hypersensitivity (DTH).
- Its chemical structure remains undefined, with a molecular weight between 2000-3500.
- TF has shown variable success in treating immunodeficiencies, neoplasms, and chronic infections.
Purpose:
- To investigate the passive transfer of DTH to tuberculin in guinea pigs using lymphocytes and leukocyte extracts.
- To explore Sephadex column fractionation of leukocyte extracts.
- To attempt in vitro characterization of TF activity using the leukocyte migration inhibition test.
Summary:
- The study reports the passive transfer of DTH to tuberculin in guinea pigs using intact lymphocytes and crude leukocyte homogenates.
- Fractionation of leukocyte extracts was performed using Sephadex columns.
- In vitro activity of extracts and fractions was assessed via leukocyte migration inhibition tests.
Impact:
- This research contributes to understanding transfer factor's properties and potential therapeutic uses.
- It highlights the challenges in developing reliable in vivo and in vitro models for TF research.
- The findings may inform future studies on TF's role in immune modulation and clinical applications.